Transforming growth factor-β signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 1, 2012, Pages

  Jaffe, Mia ^a   Sesti, Casilde ^a   Washington, Ida M ^b   Du, Liang ^a   Dronadula, Nagadhara ^a   Chin, Michael T ^a   Stolz, Donna B ^c   Davis, Elaine C ^d   Dichek, David A ^a  

^a Division of Cardiology   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

aneurysms; biology, developmental; extracellular matrix; growth factors; vascular biology

Indexed keywords

CRE RECOMBINASE; ELASTIN; RNA; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ALLELE; ANGIOGENESIS; ANIMAL EMBRYO; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DESCENDING AORTA; EMBRYO CELL; FATALITY; FEMALE; GENE EXPRESSION; HEART OUTFLOW TRACT OBSTRUCTION; HISTOCHEMISTRY; HISTOLOGY; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; BLOOD VESSELS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MYOBLASTS, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 83655167245     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.238410     Document Type: Article

References (43)

1. Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-βfamily in vascular morphogenesis and disease. Trends Cell Biol. 2010; 20:556-567.
2. Goumans MJ, Liu Z, ten Dijke P. TGF-βsignaling in vascular biology and dysfunction. Cell Res. 2009;19:116-127.
3. Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006;26:1712-1720. (Pubitemid 44305323)
4. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 1995;121:1845-1854.
5. Oshima M, Oshima H, Taketo MM. TGF-βreceptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 1996;179:297-302. (Pubitemid 26363265)
6. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβknockout phenotypes. Development. 1997;124:2659-2670. (Pubitemid 27341765)
7. Bartram U, Molin DG, Wisse LJ, Mohamad A, Sanford LP, Doetschman T, Speer CP, Poelmann RE, Gittenberger-de Groot AC. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β(2)-knockout mice. Circulation. 2001;103:2745-2752. (Pubitemid 32538792)
8. Little PJ, Tannock L, Olin KL, Chait A, Wight TN. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol. 2002;22:55-60. (Pubitemid 34076232)
9. 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
10. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 1992;90:1582-1592.
11. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
12. Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjostrand LJ, Holmdahl R, Karlsson S. Induced disruption of the transforming growth factorβtype II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 2002;100:560-568. (Pubitemid 34761120)
13. Cazac BB, Roes J. TGF-βreceptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 2000;13:443-451.
14. Chytil A, Magnuson MA, Wright CV, Moses HL. Conditional inactivation of the TGF-βtype II receptor using Cre:Lox. Genesis. 2002;32: 73-75. (Pubitemid 34211700)
15. Li L, Miano JM, Cserjesi P, Olson EN. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res. 1996;78:188-195.
16. Frutkin AD, Shi H, Otsuka G, Leveen P, Karlsson S, Dichek DA. A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre. J Mol Cell Cardiol. 2006;41:724-731. (Pubitemid 44374534)
17. Carvalho RL, Itoh F, Goumans MJ, Lebrin F, Kato M, Takahashi S, Ema M, Itoh S, van Rooijen M, Bertolino P, Ten Dijke P, Mummery CL. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβreceptors in mice. J Cell Sci. 2007;120:4269-4277.
18. Langlois D, Hneino M, Bouazza L, Parlakian A, Sasaki T, Bricca G, Li JY. Conditional inactivation of TGF-βtype II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects. Transgenic Res. 2010;19:1069-1082.
19. Wurdak H, Ittner LM, Lang KS, Leveen P, Suter U, Fischer JA, Karlsson S, Born W, Sommer L. Inactivation of TGFβsignaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 2005;19:530-535. (Pubitemid 40314985)
20. Choudhary B, Ito Y, Makita T, Sasaki T, Chai Y, Sucov HM. Cardiovascular malformations with normal smooth muscle differentiation in neural crest-specific type II TGFβreceptor (Tgfbr2) mutant mice. Dev Biol. 2006;289:420-429. (Pubitemid 43049944)
21. Choudhary B, Zhou J, Li P, Thomas S, Kaartinen V, Sucov HM. Absence of TGFβsignaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm. Genesis. 2009;47:115-121.
22. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 2003; 300:329-332. (Pubitemid 36433724)
23. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21:70-71. (Pubitemid 29036285)
24. Nagy A, Gerstenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory Press; 2003.
25. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101-1108. (Pubitemid 351818697)
26. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA. 2002;99:7142-7147. (Pubitemid 34526269)
27. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci. 2001;114:671-676. (Pubitemid 32237139)
28. Kobayashi S, Yoshida K, Ward JM, Letterio JJ, Longenecker G, Yaswen L, Mittleman B, Mozes E, Roberts AB, Karlsson S, Kulkarni AB.β2-Microglobulin- deficient background ameliorates lethal phenotype of the TGF-β1 null mouse. J Immunol. 1999;163:4013-4019. (Pubitemid 29450931)
29. Wang J, Nagy A, Larsson J, Dudas M, Sucov HM, Kaartinen V. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects. BMC Dev Biol. 2006;6:51.
30. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991;115:1091-1105. (Pubitemid 21909956)
31. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic gene expression patterns of TGFβ1,β2 andβ3 suggest different developmental functions in vivo. Development. 1991;111:131-144. (Pubitemid 21900211)
32. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
33. 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770-774. (Pubitemid 23028947)
34. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T. Transforming growth factor-β3 is required for secondary palate fusion. Nat Genet. 1995;11:409-414. (Pubitemid 3007193)
35. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393:276-280. (Pubitemid 28261728)
36. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson JA, Olson EN. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature. 2002;415:168-171. (Pubitemid 34059517)
37. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross J Jr, Honjo T, Chien KR. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature. 2002;415:171-175. (Pubitemid 34059518)
38. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, Soininen R. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation. 2002;106:2503-2509. (Pubitemid 35278809)
39. Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem. 2003;278:14387-14393. (Pubitemid 36799990)
40. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, Yanagisawa H, Zuo J, Li T. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178-182. (Pubitemid 38174378)
41. Kelleher CM, McLean SE, Mecham RP. Vascular extracellular matrix and aortic development. Curr Top Dev Biol. 2004;62:153-188. (Pubitemid 39752378)
42. Carta L, Wagenseil JE, Knutsen RH, Mariko B, Faury G, Davis EC, Starcher B, Mecham RP, Ramirez F. Discrete contributions of elastic fiber components to arterial development and mechanical compliance. Arterioscler Thromb Vasc Biol. 2009;29:2083-2089.
43. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo: two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β. Dev Biol. 1996;178:430-445. (Pubitemid 26365049)